Successful treatment of psoriasis improves psoriasis-specific but not more general aspects of patients' well-being

British Journal of Dermatology

Volumn 151, Issue 6, 2004, Pages 1219-1226

  Fortune, D G ^a   Richards, H L ^a,b   Kirby, B ^b   McElhone, K ^b   Main, C J ^a   Griffiths, C E M ^b  

^a HOPE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Disability; Distress; Psoralen plus ultraviolet A; Psoriasis; Psychology; Stress

Indexed keywords

PSORALEN;

ADULT; AGED; ANXIETY; ARTICLE; COPING BEHAVIOR; DEPRESSION; DISABILITY; DISEASE SEVERITY; DISTRESS SYNDROME; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL STRESS; PATIENT ATTITUDE; PHOTOCHEMOTHERAPY; PRIORITY JOURNAL; PSORIASIS; PUVA; SEX DIFFERENCE; WELLBEING;

ADAPTATION, PSYCHOLOGICAL; ADULT; AGED; ANXIETY; ATTITUDE TO HEALTH; CHRONIC DISEASE; DEPRESSION; DISABILITY EVALUATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PSORIASIS; PSYCHIATRIC STATUS RATING SCALES; PUVA THERAPY; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; SEX FACTORS; STRESS, PSYCHOLOGICAL;

EID: 11144339976     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2004.06222.x     Document Type: Article

References (44)

1. Rapp SR, Feldman SR, Exum ML et al. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol 1999; 41: 401-7.
2. Krueger G, Koo J, Lebwohl M et al. The impact of psoriasis on quality of life. Arch Dermatol 2001; 137: 280-4.
3. Finlay AY, Coles EC. The effect of severe psoriasis on the quality of life of 369 patients. Br J Dermatol 1995; 132: 236-44.
4. Picardi A, Abeni D, Melchi CF et al. Psychiatric morbidity in dermatological outpatients: an issue to be recognized. Br J Dermatol 1995; 132: 236-44.
5. Hill L, Kennedy P. The role of coping strategies in mediating subjective disability in people who have psoriasis. Psych Health Med 2002; 7: 261-9.
6. Richards HL, Fortune DG, Main CJ, Griffiths CEM. The contribution of perceptions of stigmatization to disability in patients with psoriasis. J Psychosom Res 2001; 50: 11-14.
7. Gupta MA, Gupta AK, Schork NJ, Ellis CN. Depression modulates pruritus perception: a study of pruritus in psoriasis, atopic dermatitis and chronic idiopathic urticaria. Psychosom Med 1994; 56: 36-40.
8. Fortune DG, Richards HL, Main CJ, Griffiths CEM. Pathological worrying, illness perceptions and disease severity in patients with psoriasis. Br J Health Psychol 2000; 5: 71-82.
9. Gupta MA, Schork NJ, Gupta AK et al. Suicidal ideation in psoriasis. Int J Dermatol 1993; 32: 188-90.
10. Fava GA, Perini GI, Santonastaso P, Veller Fornasa C. Life events and psychological distress in dermatologic disorders: psoriasis, chronic urticaria and fungal infections. Br J Med Psychol 1980; 53: 277-82.
11. Porter JR, Beuf AH, Lerner A. Psychosocial effects of vitiligo: a comparison with 'normal' control subjects, with psoriasis patients, and with patients with other pigmentary disorders. J Am Acad Dermatol 1986; 15: 220-4.
12. Al-Abadie M, Kent G, Gawkrodger D. The relationship between stress and the onset and exacerbation of psoriasis and other skin conditions. Br J Dermatol 1994; 130: 199-203.
13. Picardi A, Pasquini P, Cattaruzza MS et al. Only limited support for a role of psychosomatic factors in psoriasis: results from a case-control study. J Psychosom Res 2003; 55: 189-96.
14. Kirby B, Fortune DG, Bhushan M et al. The Salford Psoriasis Index (SPI): an holistic measure of psoriasis severity. Br J Dermatol 2000; 142: 728-32.
15. Kirby B, Richards HL, Woo P et al. Physical and psychologic measures are necessary to assess overall psoriasis severity. J Am Acad Dermatol 2001; 45: 72-6.
16. Zachariae R, Oster H, Bjerring P, Kragballe K. Effects of psychologic intervention on psoriasis: a preliminary report. J Am Acad Dermatol 1996; 34: 1008-15.
17. Price ML, Mottahedin I, Mayo PR. Can psychotherapy help with psoriasis? Clin Exp Dermatol 1991; 16: 114-17.
18. Bremer-Schulte M, Cormane RH, van Dijk E, Wuite I. Group therapy of psoriasis. Duo formula as an example. J Am Acad Dermatol 1985; 12: 61-6.
19. Devrimci-Ozguyen H, Kundakci N, Kumbasar H, Bovyat A. The depression, anxiety, life satisfaction and affective expression levels in psoriasis patients. J Eur Acad Dermatol Venereol 2000; 14: 267-71.
20. Root S, Kent G, Al-Abadie MSK. The relationship between disease severity, disability and psychological distress in patients undergoing PUVA treatment for psoriasis. Dermatology 1994; 189: 234-7.
21. Touw CR, Hakkaart-van Roijen L, Verboom P et al. Quality of life and clinical outcome in psoriasis patients using intermittent cyclosporin. Br J Dermatol 2001; 144: 967-72.
22. Gupta G, Long J, Tillman DM. The efficacy of narrowband ultraviolet B phototherapy in psoriasis using objective and subjective outcome measures. Br J Dermatol 1999; 140: 887-90.
23. Richards HL, Fortune DG, O'Sullivan TM et al. Patients with psoriasis and their compliance with medication. J Am Acad Dermatol 1999; 41: 581-3.
24. Fortune DG, Richards HL, Kirby B et al. Psychological distress impairs the rate of clearance of psoriasis in patients treated with photochemotherapy (PUVA). Arch Dermatol 2003; 139: 752-6.
25. Fredriksson T, Pettersson U. Severe psoriasis: oral therapy with a new retinoid. Dermatologica 1978; 157: 238-44.
26. Fleischer AB, Feldman SR, Rapp SR et al. Disease severity measures in a population of psoriasis patients: the symptoms of psoriasis correlate with self administered Psoriasis Area and Severity Index scores. J Invest Dermatol 1996; 107: 26-9.
27. Fortune DG, Richards HL, Kirby B et al. A cognitive-behavioural symptom management programme as an adjunct in psoriasis therapy. Br J Dermatol 2002; 146: 458-65.
28. Finlay AY, Khan GK, Luscombe D, Salek MS. Validation of Sickness Impact Profile and Psoriasis Disability Index in psoriasis. Br J Dermatol 1990; 123: 751-6.
29. Kent G, Al-Abadie M. The psoriasis disability index-further analyses. Clin Exp Dermatol 1993; 18: 414-16.
30. Fortune DG, Main CJ, O'Sullivan TM, Griffiths CEM. Quality of life in patients with psoriasis: the contribution of clinical variables and psoriasis-specific stress. Br J Dermatol 1997; 137: 755-60.
31. Gupta MA, Gupta AK. The Psoriasis Life Stress Inventory: a preliminary index of psoriasis-related stress. Acta Derm Venereol (Stockh) 1995; 75: 240-3.
32. Fortune DG, Main CJ, O'Sullivan TM, Griffiths CEM. Assessing illness-related stress in psoriasis: the psychometric properties of the Psoriasis Life Stress Inventory. J Psychosom Res 1997; 42: 467-75.
33. Zigmond A, Snaith R. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983; 67: 361-70.
34. Lewis G, Wessely S. Comparison of the General Health Questionnaire and the Hospital Anxiety and Depression Scale. Br J Psychiatry 1990; 157: 860-4.
35. Fortune DG, Richards HL, Main CJ, Griffiths CEM. Psychological stress, distress and disability in patients with psoriasis: consensus and variation in the contribution of illness perceptions, coping and alexithymia. Br J Clin Psychol 2002; 41: 157-74.
36. Meyer TJ, Miller ML, Metzger RL, Borkovec TD. Development and validation of the Penn State Worry Questionnaire. Behav Res Ther 1990; 28: 487-95.
37. Weinman J, Petrie KJ, Moss-Morris R, Home R. The Illness Perception Questionnaire: a new method for assessing the cognitive representation of illness. Psych Health 1996; 11: 114-29.
38. Fortune DG, Richards HL, Main CJ, Griffiths CEM. What patients with psoriasis believe about their condition. J Am Acad Dermatol 1998; 39: 196-201.
39. Scharloo M, Kaptein AA, Weinman J et al. Illness perceptions, coping and functioning in patients with rheumatoid arthritis, chronic obstructive pulmonary disease and psoriasis. J Psychosom Res 1998; 44: 573-85.
40. Scharloo M, Kaptein AA, Weinman J et al. Patients' illness perceptions and coping as predictors of functional status in psoriasis: a 1 year follow-up. Br J Dermatol 2000; 142: 899-907.
41. Carver CS, Scheier MF, Weintraub JK. Assessing coping strategies: a theoretically based approach. J Pers Soc Psychol 1989; 56: 267-83.
42. Bland JM, Altman DG. Multiple significance tests: the Bonferroni method. BMJ 1995; 310: 170.
43. Fortune DG. Richards HL, Main CJ, Griffiths CEM. Patients' strategies for coping with psoriasis. Clin Exp Dermatol 2002; 27: 177-84.
44. Fortune DG, Richards HL, Griffiths CEM, Main CJ. Targeting cognitive-behavioural therapy to patients' implicit model of psoriasis: results from a patient preference controlled trial. Br J Clin Psychol 2004; 43: 65-82.